Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid

Allergologia et Immunopathologia

Volumn 40, Issue 3, 2012, Pages 152-155

  Tirado Sanchez A ^a   Diaz Molina V ^a   Ponce Olivera, R M ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Adjuvant; Azathioprine; Bullous pemphigoid; Dapsone; Treatment

Indexed keywords

AZATHIOPRINE; DAPSONE; PREDNISONE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; LIVER FUNCTION TEST; MALE; MEDICAL RECORD REVIEW; PRURITUS; REMISSION; SIDE EFFECT; VERTIGO;

ADJUVANTS, IMMUNOLOGIC; AGED; AZATHIOPRINE; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PREDNISONE; RETROSPECTIVE STUDIES;

EID: 84860561201     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2010.12.009     Document Type: Article

References (12)

1. Patrício P., Ferreira C., Gomes M.M., Filipe P. Autoimmune bullous dermatoses: a review. Ann N Y Acad Sci 2009, 1173:203-210.
2. Cunha P.R., Barraviera S.R. Autoimmune bullous dermatoses. An Bras Dermatol 2009, 84:111-124.
3. Joly P., Roujeau J.C., Benichou J., Delaporte E., D'Incan M., Dreno B., et al. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol 2009, 129:1681-1687.
4. Suárez-Fernández R., España-Alonso A., Herrero-González J.E., Mascaró-Galy J.M. Practical management of the most common autoimmune bullous diseases. Actas Dermosifiliogr 2008, 99:441-455.
5. Mutasim D.F., Bilic M., Hawayek L.H., Pipitone M.A., Sluzevich J.C. Immunobullous diseases. J Am Acad Dermatol 2005, 52:1029-1043.
6. Joly P., Benichou J., Lok C., Hellot M.F., Saiag P., Tancrede-Bohin E., et al. Prediction of survival for patients with bullous pemphigoid: a prospective study. Arch Dermatol 2005, 141:691-698.
7. Khumalo N.P., Murrell D.F., Wojnarowska F., Kirtschig G. A systematic review of treatments for bullous pemphigoid. Arch Dermatol 2002, 138:385-389.
8. Beissert S., Werfel T., Frieling U., Böhm M., Sticherling M., Stadler R., et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol 2007, 143:1536-1542.
9. Patel A.A., Swerlick R.A., McCall C.O. Azathioprine in dermatology: the past, the present, and the future. J Am Acad Dermatol 2006, 55:369-389.
10. Mutasim D.F. Management of autoimmune bullous diseases: pharmacology and therapeutics. J Am Acad Dermatol 2004, 51:859-877.
11. Kazlow Stern D., Tripp J.M., Ho V.C., Lebwohl M. The use of systemic immune moderators in dermatology: an update. Dermatol Clin 2005, 23:259-300.
12. Gürcan H.M., Ahmed A.R. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data. Am J Clin Dermatol 2009, 10:383-396.